Xeloda Black Box Warning Added Due toBleeding Risk with Blood Thinner Use
The FDA has added a new black box warning to Xeloda, a cancer drug which may increase the risk of bleeding when used with certain blood thinners.
The FDA has added a new black box warning to Xeloda, a cancer drug which may increase the risk of bleeding when used with certain blood thinners.
An FDA advisory committee voted to recommend the agency not approve Copiktra for some blood cancer patients due to an increased risk of death.
An advisory committee is being asked to review the benefits and risks of Copiktra, a blood cancer drug FDA experts say appears to lower life expectancy in some cancer patients.
The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.